What is clopidogrel used for
Pro Research Analysisby 
Searched over 200M research papers
Consensus Meter
Clopidogrel: Uses and Clinical Applications
Clopidogrel for Cardiovascular Disease Prevention
Clopidogrel is primarily used as an antiplatelet medication to reduce the risk of atherosclerotic events such as myocardial infarction, ischemic stroke, and vascular death in patients with atherosclerosis. This includes individuals with recent stroke, myocardial infarction, or established peripheral vascular disease. The CAPRIE study demonstrated that clopidogrel significantly lowers the annual risk of combined ischemic events compared to aspirin, making it a preferred choice for patients with a history of coronary artery bypass surgery, diabetes mellitus, or those on lipid-lowering therapy.
Dual Antiplatelet Therapy (DAPT) in Acute Coronary Syndrome (ACS)
Clopidogrel is often used in combination with aspirin as part of dual antiplatelet therapy (DAPT) for the secondary prevention of acute coronary syndrome (ACS). The CURE trial showed that clopidogrel combined with aspirin is more effective than aspirin alone in reducing the composite outcome of death from cardiovascular causes, non-fatal myocardial infarction, or stroke in patients with non-ST-segment elevation ACS. However, this combination is associated with an increased risk of bleeding.
Clopidogrel in Minor Stroke and Transient Ischemic Attack (TIA)
For patients with minor ischemic stroke or high-risk TIA, clopidogrel combined with aspirin has been shown to reduce the risk of major ischemic events. The CHANCE and POINT trials indicated that the benefit of this dual therapy is most significant within the first 21 days after the event. This combination therapy is recommended for short-term use, followed by clopidogrel monotherapy for up to 90 days.
Peripheral Artery Disease (PAD)
Clopidogrel is also used in patients with symptomatic peripheral artery disease (PAD). It helps in reducing the risk of ischemic events and is often preferred over aspirin due to its better gastrointestinal tolerability .
Safety and Adverse Effects
While clopidogrel is effective in preventing atherothrombotic events, it is associated with an increased risk of bleeding, especially when used in combination with other antiplatelet agents like aspirin or warfarin. Higher loading doses of clopidogrel are linked to increased bleeding risks, and its use can lead to conditions such as thrombotic thrombocytopenic purpura, although this is rare. Additionally, clopidogrel has been associated with hypoglycemia, particularly in Asian populations, which necessitates careful monitoring.
Clopidogrel Resistance
Clopidogrel resistance, or high on-treatment platelet reactivity, is a phenomenon where patients do not respond adequately to the drug, leading to a higher risk of recurrent vascular events. Factors contributing to this resistance include genetic polymorphisms, concomitant drug use, and certain vascular risk factors like diabetes. Platelet function testing may be beneficial in identifying and managing patients predisposed to clopidogrel resistance.
Conclusion
Clopidogrel is a cornerstone antiplatelet therapy used in various cardiovascular conditions, including ACS, minor stroke, TIA, and PAD. Its combination with aspirin in dual antiplatelet therapy significantly reduces the risk of ischemic events but comes with an increased risk of bleeding. Understanding the balance between its benefits and risks, as well as managing clopidogrel resistance, is crucial for optimizing patient outcomes.
Sources and full results
Most relevant research papers on this topic